Skip to main content
. 2020 Dec 18;35(50):e434. doi: 10.3346/jkms.2020.35.e434

Table 1. Baseline characteristics of participants.

Characteristics Total (n = 7,341) Non-CKD (n = 7,088) ND-CKD (n = 239) DD-CKD (n =14) P value
Sex, male 4,371 (59.5) 4,241 (59.8) 122 (51.0) 8 (57.1) 0.024
Age, yr 47.1 ± 19.0 46.5 ± 18.9 63.0 ± 14.8a 59.6 ± 14.5a < 0.001
Follow-up duration, day 20.8 ± 13.1 20.7 ± 13.0 24.5 ± 14.8a 22.7 ± 15.6a < 0.001
Myocardial infarction 97 (1.3) 78 (1.1) 19 (8.0) 0 < 0.001
Congestive heart failure 297 (4.0) 247 (3.5) 45 (18.8) 5 (35.7) < 0.001
Peripheral vascular disease 573 (7.8) 516 (7.3) 54 (22.6) 3 (21.4) < 0.001
Cerebrovascular disease 522 (7.1) 470 (6.6) 48 (20.1) 4 (28.6) < 0.001
Dementia 443 (6.0) 410 (5.8) 33 (13.8) 0 < 0.001
Chronic pulmonary disease 1,676 (22.8) 1,586 (22.4) 84 (35.2) 6 (42.9) < 0.001
Connective tissue disease 268 (3.7) 241 (3.4) 27 (11.3) 0 < 0.001
Peptic ulcer disease 1,102 (15.0) 1,041 (14.7) 58 (24.3) 3 (21.4) < 0.001
Mild liver disease 1,545 (21.0) 1,384 (19.53) 156 (65.3) 5 (35.7) < 0.001
Diabetes mellitus 1,230 (16.8) 1,033 (14.6) 190 (79.5) 7 (50) < 0.001
Hemiplegia 100 (1.4) 95 (1.3) 4 (1.7) 1 (7.1) 0.159
Any malignancy 359 (4.9) 330 (4.7) 28 (11.7) 1 (7.1) < 0.001
Moderate to severe liver disease 9 (0.1) 7 (0.1) 2 (0.8) 0 0.006
Metastatic tumor 33 (0.4) 29 (0.4) 4 (1.7) 0 0.016
Acquired immune deficiency syndrome 5 (0.1) 4 (0.1) 1 (0.4) 0 0.108
Hypertension 1,572 (21.4) 1,400 (19.8) 159 (66.5) 13 (92.9) < 0.001

Data are expressed as number (%) for categorical variables and mean ± standard deviation for continuous variables. The P values were assessed using one-way analysis of variance, followed by Bonferroni's post hoc test for continuous variables and Pearson χ2 test or Fisher exact test for categorical variables.

Non-CKD = non-chronic kidney disease, ND-CKD = non-dialysis-chronic kidney disease, DD-CKD = dialysis dependent chronic kidney disease.

aP < 0.05 vs. Non-CKD group.